Influence of Epilepsy Characteristics on the Anxiety Occurrence

The presence of anxiety in individuals with epilepsy significantly influences their medical treatment and quality of life and often goes unrecognized or untreated, posing a challenge to differential diagnosis. The study aimed to investigate the influence of epilepsy characteristics on anxiety. The research involved 155 patients with generalized and focal drug-sensitive [DSE] and drug-resistant [DRE] epilepsy. Hamilton anxiety rating scale [HAS] was used to assess the symptoms of anxiety at three time points [baseline, 12, and 18 months]. DSE patients exhibited significantly lower HAM-A scores than patients with DRE at the initial visit [<i>p</i> = 0.000] after 12 [<i>p</i> = 0.000] and 18-month follow-up [<i>p</i> = 0.000]. Focal DRE patients presented higher HAM-A scores than focal DSE patients in the initial visit [<i>p</i> = 0.000] after 12 [<i>p</i> = 0.000] and 18 months [<i>p</i> = 0.000]. Medication responsiveness, seizure type, and illness duration emerged as significant anxiety predictors [<i>p</i> = 0.000]. After 18 months of follow-up, significant contributors to anxiety were drug responsivity and illness duration [<i>p</i> = 0.000]. The occurrence of anxiety in epilepsy patients is most significantly influenced by well-controlled epilepsy and a positive response to medication.